PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53
出版年份 2018 全文链接
标题
PARP-1 inhibition with or without ionizing radiation confers reactive oxygen species-mediated cytotoxicity preferentially to cancer cells with mutant TP53
作者
关键词
-
出版物
ONCOGENE
Volume 37, Issue 21, Pages 2793-2805
出版商
Springer Nature
发表日期
2018-03-05
DOI
10.1038/s41388-018-0130-6
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Poly(ADP-ribose) polymerase activity and inhibition in cancer
- (2017) Caleb Dulaney et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Improving the Predictive Value of Preclinical Studies in Support of Radiotherapy Clinical Trials
- (2016) C. N. Coleman et al. CLINICAL CANCER RESEARCH
- Bladder cancer
- (2016) Ashish M Kamat et al. LANCET
- Laying a trap to kill cancer cells: PARP inhibitors and their mechanisms of action
- (2016) Y. Pommier et al. Science Translational Medicine
- PARP1 inhibition radiosensitizes HNSCC cells deficient in homologous recombination by disabling the DNA replication fork elongation response
- (2016) Stephanie Wurster et al. Oncotarget
- Lung Cancer Cell Line Screen Links Fanconi Anemia/BRCA Pathway Defects to Increased Relative Biological Effectiveness of Proton Radiation
- (2015) Qi Liu et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Adapting a Drug Screening Platform to Discover Associations of Molecular Targeted Radiosensitizers with Genomic Biomarkers
- (2015) Qi Liu et al. MOLECULAR CANCER RESEARCH
- PARP Inhibitors Sensitize Ewing Sarcoma Cells to Temozolomide-Induced Apoptosis via the Mitochondrial Pathway
- (2015) F. Engert et al. MOLECULAR CANCER THERAPEUTICS
- Chromatin to Clinic: The Molecular Rationale for PARP1 Inhibitor Function
- (2015) Felix Y. Feng et al. MOLECULAR CELL
- In vivo studies of the PARP inhibitor, AZD-2281, in combination with fractionated radiotherapy: An exploration of the therapeutic ratio
- (2015) Cihan Gani et al. RADIOTHERAPY AND ONCOLOGY
- Extent of radiosensitization by the PARP inhibitor olaparib depends on its dose, the radiation dose and the integrity of the homologous recombination pathway of tumor cells
- (2015) Caroline V.M. Verhagen et al. RADIOTHERAPY AND ONCOLOGY
- Niraparib (MK-4827), a novel poly(ADP-Ribose) polymerase inhibitor, radiosensitizes human lung and breast cancer cells
- (2015) Kathleen A. Bridges et al. Oncotarget
- Nox4: A Hydrogen Peroxide-Generating Oxygen Sensor
- (2014) Yukio Nisimoto et al. BIOCHEMISTRY
- EGFR-Mediated Chromatin Condensation Protects KRAS-Mutant Cancer Cells against Ionizing Radiation
- (2014) M. Wang et al. CANCER RESEARCH
- Modulation of the poly (ADP-ribose) polymerase inhibitor response and DNA recombination in breast cancer cells by drugs affecting endogenous wild-type p53
- (2014) Ivanildce Cristiane Ireno et al. CARCINOGENESIS
- Inhibition of PARP1-dependent end-joining contributes to Olaparib-mediated radiosensitization in tumor cells
- (2014) Annika Kötter et al. Molecular Oncology
- Somatic ERCC2 Mutations Correlate with Cisplatin Sensitivity in Muscle-Invasive Urothelial Carcinoma
- (2014) E. M. Van Allen et al. Cancer Discovery
- Detection of Impaired Homologous Recombination Repair in NSCLC Cells and Tissues
- (2013) Moritz Birkelbach et al. Journal of Thoracic Oncology
- Combining PARP-1 Inhibition and Radiation in Ewing Sarcoma Results in Lethal DNA Damage
- (2013) Hae-June Lee et al. MOLECULAR CANCER THERAPEUTICS
- Modulation of oxidative stress as an anticancer strategy
- (2013) Chiara Gorrini et al. NATURE REVIEWS DRUG DISCOVERY
- Predictive biomarkers for cancer therapy with PARP inhibitors
- (2013) J Michels et al. ONCOGENE
- Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors
- (2012) J. Murai et al. CANCER RESEARCH
- Pro-Oxidant Natural Products as Anticancer Agents
- (2012) Carmen Martin-Cordero et al. CURRENT DRUG TARGETS
- New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs
- (2012) Bryan A. Gibson et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The cBio Cancer Genomics Portal: An Open Platform for Exploring Multidimensional Cancer Genomics Data: Figure 1.
- (2012) Ethan Cerami et al. Cancer Discovery
- Redox Regulation of p53, Redox Effectors Regulated by p53: A Subtle Balance
- (2011) Agnès Maillet et al. ANTIOXIDANTS & REDOX SIGNALING
- Mechanistic Rationale for Inhibition of Poly(ADP-Ribose) Polymerase in ETS Gene Fusion-Positive Prostate Cancer
- (2011) J. Chad Brenner et al. CANCER CELL
- EGF Receptor Inhibition Radiosensitizes NSCLC Cells by Inducing Senescence in Cells Sustaining DNA Double-Strand Breaks
- (2011) M. Wang et al. CANCER RESEARCH
- PARP-1 Inhibition Increases Mitochondrial Metabolism through SIRT1 Activation
- (2011) Péter Bai et al. Cell Metabolism
- Inhibition of PARP-1 by Olaparib (AZD2281) Increases the Radiosensitivity of a Lung Tumor Xenograft
- (2011) J. M. Senra et al. MOLECULAR CANCER THERAPEUTICS
- Contextual Synthetic Lethality of Cancer Cell Kill Based on the Tumor Microenvironment
- (2010) N. Chan et al. CANCER RESEARCH
- Expression Signature of E2F1 and Its Associated Genes Predict Superficial to Invasive Progression of Bladder Tumors
- (2010) Ju-Seog Lee et al. JOURNAL OF CLINICAL ONCOLOGY
- Poly (ADP-ribose) polymerase (PARP) is not involved in base excision repair but PARP inhibition traps a single-strand intermediate
- (2010) C. E. Strom et al. NUCLEIC ACIDS RESEARCH
- Poly(ADP-Ribose) Polymerase Inhibition as a Model for Synthetic Lethality in Developing Radiation Oncology Targets
- (2010) Anthony J. Chalmers et al. SEMINARS IN RADIATION ONCOLOGY
- PARP is activated at stalled forks to mediate Mre11-dependent replication restart and recombination
- (2009) Helen E Bryant et al. EMBO JOURNAL
- Mitochondrial Localization of PARP-1 Requires Interaction with Mitofilin and Is Involved in the Maintenance of Mitochondrial DNA Integrity
- (2009) Marianna N. Rossi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
- (2009) Dunyaporn Trachootham et al. NATURE REVIEWS DRUG DISCOVERY
- Altered redox status accompanies progression to metastatic human bladder cancer
- (2008) N HEMPEL et al. FREE RADICAL BIOLOGY AND MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started